Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-098440

Co-Chief Executive Officer acquired 248,865 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cohen Joshua B · Co-Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-05 Grant or award : show line 1 in the form +248,865 3,583,548 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-05 Grant or award : show line 2 in the form Stock Option (Right to Buy) +373,295 373,295 D
Loading xslF345X05/ownership.xml…